Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA - Quiz - MDSpire

Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA

  • By

  • Tarannum Jaleel

  • Raj Chovatiya

  • Elizabeth D. Bacci

  • Evangeline Pierce

  • Melissa L. Constantine

  • Julia R. Correll

  • Beth Mitchell

  • Dipak R. Patel

  • Brindley Brooks

  • Candrice Heath

  • Vivian Y. Shi

  • May 2, 2026

  • 0 min

Share

Original Source(s)

Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA

  • by Tarannum Jaleel, Raj Chovatiya, Elizabeth D. Bacci, Evangeline Pierce, Melissa L. Constantine, Julia R. Correll, Beth Mitchell, Dipak R. Patel, Brindley Brooks, Candrice Heath, Vivian Y. Shi

  • May 2, 2026

Related Content

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase

Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society